203 related articles for article (PubMed ID: 23590655)
1. Immunophenotyping of selected hematologic disorders--focus on lymphoproliferative disorders with more than one malignant cell population.
Porwit A
Int J Lab Hematol; 2013 Jun; 35(3):275-82. PubMed ID: 23590655
[TBL] [Abstract][Full Text] [Related]
2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
3. Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube.
Rajab A; Porwit A
Cytometry B Clin Cytom; 2015; 88(4):253-60. PubMed ID: 25664445
[TBL] [Abstract][Full Text] [Related]
4. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
[TBL] [Abstract][Full Text] [Related]
5. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets.
Mittag A; Lenz D; Gerstner AO; Sack U; Steinbrecher M; Koksch M; Raffael A; Bocsi J; Tárnok A
Cytometry A; 2005 Jun; 65(2):103-15. PubMed ID: 15830380
[TBL] [Abstract][Full Text] [Related]
6. Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies.
Babusíková O; Stevulová L
Neoplasma; 2004; 51(6):422-30. PubMed ID: 15640950
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a 10color protocol as part of a 2tube screening panel for flow cytometric assessment of peripheral blood leukocytic subsets.
Gounari E; Tsavdaridou V; Ioakeimidou A; Haidich AB; Skoura L
Scand J Clin Lab Invest; 2019 Nov; 79(7):475-483. PubMed ID: 31497995
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program.
Schenker EL; Hultin LE; Bauer KD; Ferbas J; Margolick JB; Giorgi JV
Cytometry; 1993; 14(3):307-17. PubMed ID: 8472607
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
[TBL] [Abstract][Full Text] [Related]
11. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting.
Braylan RC; Orfao A; Borowitz MJ; Davis BH
Cytometry; 2001 Feb; 46(1):23-7. PubMed ID: 11241503
[TBL] [Abstract][Full Text] [Related]
12. Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-Hodgkin lymphoma: a critical review of 307 cases with technical suggestions.
Zeppa P; Marino G; Troncone G; Fulciniti F; De Renzo A; Picardi M; Benincasa G; Rotoli B; Vetrani A; Palombini L
Cancer; 2004 Feb; 102(1):55-65. PubMed ID: 14968418
[TBL] [Abstract][Full Text] [Related]
13. Initial flow cytometric evaluation of the Clearllab lymphoid screen.
Hedley BD; Cheng G; Luider J; Kern W; Lozanski G; Chin-Yee I; Lowes LE; Keeney M; Careaga D; Magari R; Tejidor L
Cytometry B Clin Cytom; 2018 Sep; 94(5):707-713. PubMed ID: 29171939
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric assessment of T-cell chronic lymphoproliferative disorders.
Cady FM; Morice WG
Clin Lab Med; 2007 Sep; 27(3):513-32, vi. PubMed ID: 17658405
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Li S; Juco J; Mann KP; Holden JT
Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
[TBL] [Abstract][Full Text] [Related]
16. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry.
Segal GH; Edinger MG; Owen M; McNealis M; Lopez P; Perkins A; Linden MD; Fishleder AJ; Stoler MH; Tubbs RR
Cytometry; 1991; 12(4):350-9. PubMed ID: 1712263
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
18. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
Rothe G; Schmitz G
Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
[TBL] [Abstract][Full Text] [Related]
19. A practical approach to the flow cytometric detection and diagnosis of T-cell lymphoproliferative disorders.
Meyerson HJ
Lab Hematol; 2010 Sep; 16(3):32-52. PubMed ID: 20858587
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
